Follow the Qiagen N.V. stock price and the full insider trade history of the company, a listed issuer based in Netherlands. Shares are quoted on the NL market, under the authority of AFM. Operating in the Health Care sector, Qiagen N.V. has published 349 reports. Market capitalisation: €8.9bn. The latest transaction was reported on 11 August 2026 (Purchase). Among the most active insiders: R. Sackers. The full history is accessible without an account.
349
Insider Decl.
n/a
Thresholds
€1bn
91 ops.
Buy Volume
€187m
95 ops.
Sell Volume
Analyst consensus: bullish or bearish?
Analysts rate Qiagen N.V. Buy (bullish), based on 14 analysts. Average price target: US$46.07.
25Σ signal
Buys €1bn€187m Sells
Fundamental score
Ranked 8,393 of 29,056 companies
62.0
score / 100
Value
55
Quality
69
FCF yld5.0%
Earn yld4.8%
EV/EBITDA15.0x
ROE12%
Gross mgn62%
Net mgn20%
Debt/EBITDA2.5x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
Qiagen N.V. es una empresa especializada en tecnologías de biología molecular, que ofrece soluciones para diagnóstico e investigación. Cotiza en la Bolsa de Ámsterdam.